Phase 2 Oesophageal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with a type of esophageal cancer called squamous cell carcinoma that cannot be removed by surgery and has either spread locally or to other parts of the body (confirmed by a biopsy or cell test)
- Your cancer has gotten worse after trying 1 or 2 previous treatments for this condition
- Your cancer can be measured on scans or tests
- If you have HIV, it is well-controlled with medication
- Your organs (such as kidneys, liver, and heart) are working well enough as determined by your doctor
Who may not be able to join:
- Your esophageal cancer has been confirmed to be a different type, called adenocarcinoma or adenosquamous carcinoma
- You have fluid build-up around your lungs, heart, or abdomen that is difficult to control and needs frequent draining or medical treatment
- You have a significant eye or cornea condition
- You have had a stroke, mini-stroke, or another blood clot event affecting an artery in the past 6 months
- You have HIV and also have a history of a condition called Kaposi's sarcoma or Multicentric Castleman's Disease
- You have heart or blood vessel disease that is not well controlled
- You have or are being treated for another cancer that has been active or required treatment in the past 3 years
- Your cancer has spread to your brain or the lining around your brain and spine in an active way
- You have ever had a lung condition called interstitial lung disease (ILD) or pneumonitis, except for a specific type caused by radiation that did not need steroid treatment (confirm with trial site)
- You currently have an active infection that requires treatment through a drip or medication (other than certain permitted treatments)
- You have serious lung problems caused by other illnesses, including conditions such as severe asthma, severe COPD, blood clots in the lungs within the last 3 months, restricted lung function, autoimmune diseases affecting the lungs, or if you have had a lung removed or currently need extra oxygen to breathe
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Medical Director, Merck Sharp & Dohme LLC
Phone: 1-888-577-8839
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Objective Response Rate (ORR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.